RITUXIMAB
| Source | S100 HSD Private |
| Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES |
|
|
| Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
|---|---|---|---|---|---|---|---|
| 13095FMP | RITUXIMAB rituximab 500 mg/50 mL injection, 50 mL vial (PI, CMI) |
2 | 2 | 1 | $458.54 | $31.60 | $31.60 |
| Available brands | |||||||
| Riximyoa | |||||||
| Ruxiencea | |||||||
| Truximaa |
- Legend
- aBrand equivalent a
- MPMedical Practitioner




